If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
157.50    0.20 (0.13%)
Bid:
157.30
Ask:
158.30
Spread: 1.00 (0.636%)
Market Cap: £1.64b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Director/PDMR Shareholding

12 Aug 2025 14:41

RNS Number : 0382V
Currys PLC
12 August 2025
 

12 August 2025

CURRYS PLC

NOTIFICATION OF TRANSACTION OF DIRECTOR

Award under the 2022/23 Deferred Share Bonus Plan ("DSBP")

In accordance with the requirements of DTR 3.1 and Market Abuse Regulation Article 19, Currys plc (the 'Company') announces the following share transaction undertaken by Alex Baldock, Group Chief Executive (a PDMR).

Alex Baldock exercised nil cost options over ordinary shares of 0.1 pence in the Company in respect of the 2022/23 DSBP Award (the "Award") which was granted on the 3 August 2023 under the DSBP. The Award vested on 3 August 2025, and Alex subsequently exercised a total of 288,617 options and sold 136,128 shares to cover the tax liability arising on the transaction. The remaining 152,489 shares were retained.

PMDR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alex Baldock

2

Reason for the notification

a)

Position/status

Group Chief Executive

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Currys plc

b)

LEI

2138001E12GWLLDQQF16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 0.1p each in Currys plc

Identification code

GB00B4Y7R145

b)

Nature of the transaction

Exercise of a share option under the Currys Deferred Share Bonus Plan and sale of shares to cover the tax and NIC arising from the exercise.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

288,617

£1.131

136,128

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

288,617

 £0.00

 

2. Sale

Price(s)

Volume(s)

Total

£1.131

136,128

 £153,961

e)

Date of the transaction

(DD-MM-YYYY)

12-08-2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Sarah Thomas Deputy Company Secretary +44 (0)7401 373 188

 

Dan Homan Investor Relations Director +44 (0)7401 400 442

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIGSBDGUD
Date   Source Headline
19th Feb 20247:00 amRNSStatement re Possible Offer
8th Feb 20245:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20249:51 amRNS2023 AGM Results - update statement
1st Feb 20249:44 amRNSTotal Voting Rights
18th Jan 20243:11 pmRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSStrengthening performance in a tough environment
2nd Jan 202412:52 pmRNSTotal Voting Rights
21st Dec 20232:54 pmRNSHolding(s) in Company
21st Dec 202310:40 amRNSHolding(s) in Company
20th Dec 20239:54 amRNSHolding(s) in Company
14th Dec 20235:24 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSSolid performance in a tough environment
1st Dec 20239:06 amRNSTotal Voting Rights
21st Nov 202312:01 pmRNSResult of Meeting
3rd Nov 202312:25 pmRNSShareholder Circular and Notice of General Meeting
3rd Nov 20237:05 amRNSProposed Disposal of Kotsovolos
1st Nov 20239:41 amRNSTotal Voting Rights
10th Oct 20237:27 amRNSUpdate on Strategic Review of Kotsovolos
6th Oct 20233:16 pmRNSHolding(s) in Company
2nd Oct 202311:26 amRNSTotal Voting Rights
28th Sep 202310:55 amRNSHolding(s) in Company
20th Sep 202310:35 amRNSDirector/PDMR Shareholding
19th Sep 202310:35 amRNSHolding(s) in Company
7th Sep 20231:51 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM Trading Statement
1st Sep 20239:09 amRNSTotal Voting Rights
22nd Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 202312:40 pmRNSDirector/PDMR Shareholding
4th Aug 20239:44 amRNSDirector/PDMR Shareholding
3rd Aug 202312:54 pmRNSAnnual Financial Report
3rd Aug 20239:25 amRNSDirector/PDMR Shareholding
1st Aug 202311:09 amRNSTotal Voting Rights
28th Jul 202310:58 amRNSDirector/PDMR Shareholding
13th Jul 20238:30 amRNSHolding(s) in Company
12th Jul 20234:14 pmRNSHolding(s) in Company
11th Jul 20239:42 amRNSHolding(s) in Company
10th Jul 20232:59 pmRNSDirector/PDMR Shareholding
7th Jul 202310:36 amRNSDirector/PDMR Shareholding
6th Jul 20231:26 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSStrengthening UK&I offset by poor Nordics
3rd Jul 20239:55 amRNSTotal Voting Rights
26th Jun 202312:14 pmRNSHolding(s) in Company
23rd Jun 20234:23 pmRNSHolding(s) in Company
22nd Jun 20239:22 amRNSHolding(s) in Company
19th Jun 20235:20 pmRNSHolding(s) in Company
19th Jun 20234:38 pmRNSHolding(s) in Company
16th Jun 20237:00 amRNSStrategic Review of Kotsovolos
2nd Jun 202310:37 amRNSDirectorate Change
1st Jun 20239:33 amRNSTotal Voting Rights
24th May 20238:37 amRNSResponse to ESA announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.